Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 17.28 (+0.06), HBNK: 20.95 (+0.10), BRDR: 8.52 (+0.05), SAPE: 24.81 (-0.01), TAIT: 1.01 (-0.01), BASI: 2.09 (-0.11), GERN: 3.06 (+0.05), NYMX: 0.38 (unch), MTEX: 28.96 (unch), CKEC: 26.09 (+0.10), ALQA: 3.96 (-0.02)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
HBNK: 20.95 (+0.10), ASMI: 41.60 (-0.28), VBFC: 24.00 (+1.22), RRGB: 76.51 (+0.13), SAPE: 24.81 (-0.01), ODP: 8.75 (+0.06), RMTI: 8.41 (-0.07), MTEX: 28.96 (unch), JAXB: 12.26 (+0.96), ALQA: 3.96 (-0.02)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 7.61 (unch), NEO: 4.03 (-0.10), AU: 8.39 (+0.24), FNHC: 25.30 (+0.45), AMS: 2.50 (-0.02), NYMX: 0.38 (unch), AMDA: 0.64 (-0.01), CVD: 103.73 (+0.02), GBIM: 7.29 (unch), RCAP: 11.23 (+0.26), KBIO: 1.63 (-0.04), COOL: 1.15 (+0.14), SAPE: 24.81 (-0.01), XTLB: 2.21 (+0.03), GERN: 3.06 (+0.05), ANIP: 55.24 (+1.79), BBLU: 1.15 (-0.03), NXTD: 2.46 (-0.09), AP: 19.03 (+0.47), ALQA: 3.96 (-0.02)
Alliqua's Biovance gets additional reimbursement code
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:54AM CST
ALQA: 3.96 (-0.02)
Alliqua BioMedical, Inc.'s Biovance(R) Assigned Level II HCPCS Q Code for Product Reimbursement
GlobeNewswire - Mon Nov 03, 6:30AM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
More on Alliqua BioMedical Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 4:16PM CDT
ALQA: 3.96 (-0.02)
Alliqua's (ALQA) CEO David Johnson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55PM CDT
ALQA: 3.96 (-0.02)
Alliqua misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:06PM CDT
ALQA: 3.96 (-0.02)
Alliqua BioMedical, Inc. Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 30, 3:49PM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua BioMedical, Inc. to Announce Third Quarter Financial Results on October 30th
Marketwired - Thu Oct 23, 3:37PM CDT
Alliqua BioMedical, Inc. (NASDAQ: ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Abstract on Alliqua's Biovance(R) Product to Receive Award at the Fall 2014 Symposium on Advanced Wound Care
GlobeNewswire - Mon Oct 13, 6:30AM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua Biomedical amends exclusive licensing agreement for Biovance to include podiatric and orthopedic applications
M2 - Tue Oct 07, 7:06AM CDT
Wound care company Alliqua Biomedical (NaddaqCM:ALQA) said on Monday that it has expanded and amended its exclusive licensing agreement with Celgene Cellular Therapeutics, a subsidiary of Celgene.
ALQA: 3.96 (-0.02), CELGZ: 3.34 (-0.01)
Alliqua Biomedical Announces Expansion to Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
GlobeNewswire - Mon Oct 06, 6:30AM CDT
Amendment Expands Field of Use for Biovance(R) to Include Podiatric and Orthopedic Applications
ALQA: 3.96 (-0.02), CELGZ: 3.34 (-0.01)
Alliqua BioMedical to Present at Upcoming Investor Conferences
GlobeNewswire - Tue Sep 02, 6:30AM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua Biomedical, Inc. Reports Second Quarter 2014 Financial Results
GlobeNewswire - Mon Aug 11, 6:38AM CDT
Alliqua Biomedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua BioMedical Announces Changes to Its Board of Directors
GlobeNewswire - Tue Jul 22, 6:30AM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua BioMedical's CEO Issues Midyear Corporate Update for Shareholders
GlobeNewswire - Thu Jul 10, 6:30AM CDT
David Johnson, Chief Executive Officer of Alliqua Biomedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)
Alliqua BioMedical Added to the Russell Microcap(R) Index
GlobeNewswire - Mon Jun 30, 11:15AM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
ALQA: 3.96 (-0.02)